A Phase Ib/II Trial of Lisaftoclax in Combination With PolaRCHP or RCHOP Regimens for Patients With Previously Untreated Diffuse Large B Cell Lymphoma (ChiCTR) - Oct 16, 2026 - P1/2 | N=139 | Not yet recruiting | Sponsor: West China Hospital of Sichuan University; West China Hospital of Sichuan University
New P1/2 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • BCL2
|